Members of the ®broblast growth factor (Fgf) family are important signaling molecules in several inductive and patterning processes, and act as brain organizer-derived signals during formation of the early vertebrate nervous system. We isolated a new member of the Fgf8/17/18 subgroup of Fgfs from the zebra®sh, and studied its expression and function during somitogenesis, optic stalk and midbrain-hindbrain boundary (MHB) development. In spite of a slightly higher aminoacid similarity to Fgf8, expression analysis and mapping to a chromosome stretch that is syntenic with mammalian chromosomes shows that this gene is orthologous to mammalian Fgf17. These data provide a further example of conserved chromosomal organization between zebra®sh and mammalian genomes. Using an mRNA injection assay, we show that fgf17 can act similar to fgf8 during gastrulation, when fgf17 is not normally expressed. Direct comparison of the expression patterns of fgf17 and fgf8 suggest however a possible cooperation of these Fgfs at later stages in several tissues requiring Fgf signaling. Analysis of zebra®sh MHB mutants demonstrates a gene-dosage dependent requirement of fgf17 expression for the no isthmus// pax2.1 gene, showing that no isthmus/pax2.1 functions upstream of fgf17 at the MHB in a haplo-insuf®cient manner, similar to what has been reported for mammalian pax2 mutants. In contrast, only maintenance of fgf17 expression is disturbed at the MHB of acerebellar/fgf8 mutants. Consistent with a requirement for fgf8 function, implantation of FGF8-soaked beads induces fgf17 expression, and expression is upregulated in aussicht mutants, which display upregulation of the Fgf8 signaling pathway. Taken together, our results argue that Fgf8 and Fgf17 act as hierarchically organized signaling molecules during development of the MHB organizer and possibly other organizers in the developing nervous system. q
Introduction
Subdivision of the vertebrate neural plate is regulated by the activity of distinct cell populations with organizing character (Marin and Puelles, 1994; Lumsden and Krumlauf, 1996; Houart et al., 1998) . One such cell population is located in the boundary territory between midbrain and hindbrain (MHB), which at later stages forms the isthmus rhombencephali (Alvarado-Mallart, 1993; Wassef et al., 1993; Nakamura et al., 1994; Marin and Puelles, 1994; Bally-Cuif and Wassef, 1995; Joyner, 1996; Puelles et al., 1996; Wassef and Joyner, 1997; Brand, 1998) . Transplantation experiments in the chick embryo suggested that the MHB functions as an organizing center which in¯uences the fate of the surrounding neural tube cells. When MHB tissue is grafted into caudal forebrain or hindbrain, ectopic midbrain or cerebellar structures are induced, respectively (Gardner and Barald, 1991; Martinez et al., 1991 Martinez et al., , 1995 Bally-Cuif et al., 1992; Marin and Puelles, 1994) .
Several molecules are expressed at the MHB that are important for the activity of the MHB organizer. For several transcription factors, such as En1 and En2 Millen et al., 1994) , Pax2 (Torres et al., 1995; Brand et al., 1996; Favor et al., 1996; Lun and Brand, 1998) , Pax5 (Urbanek et al., 1994) , Otx1 and Otx2 (Ang et al., 1996; Acampora et al., 1997) and Gbx2 (Wassarman et al., 1997) , a requirement during development and/or function of the MHB has been demonstrated. Among the secreted factors, the vertebrate homolog of Drosophila Wingless, Wnt1 (Thomas and Capecchi, 1990; McMahon et al., 1992) and Fgf8, a member of the ®broblast growth factor family, are required for MHB development in mice (Meyers et al., 1998) and zebra®sh (Reifers et al., 1998; Picker et al., 1999) .
To better understand the function of the MHB organizer, the analysis of loss-of-function mutants has been of great value. In zebra®sh, lethal mutations in four genes affect development of the MHB. Homozygous acerebellar (ace; Brand et al., 1996) and spiel-ohne-grenzen (spg; Schier et al., 1996) embryos lack the MHB and the cerebellum, but retain a midbrain. acerebellar is a mutation in the zebra®sh fgf8 gene (Reifers et al., 1998) . In aussicht (aus; Heisenberg et al., 1999 ) mutant embryos fgf8 is upregulated in most of its expression sites, suggesting that aus may be involved in feedback-regulation of fgf8 transcription. Embryos homozygous for no isthmus (noi) lack the MHB and cerebellum, as well as the midbrain, and noi mutations inactivate the pax2.1 transcription factor (Brand et al., 1996; Lun and Brand, 1998) ; the genes affected by spg and aus are not yet known.
Fibroblast growth factors (Fgfs) in general serve as signaling molecules during development. For instance, injection of dominant negative Fgf receptor constructs in Xenopus and zebra®sh leads to posterior truncation, demonstrating that Fgf signaling is required during gastrulation and mesoderm development (Grif®n et al., 1995; Kroll and Amaya, 1996) . The Fgf family consists of at least 19 members in vertebrates (Xu et al., 1999; Nishimura et al., 1999; Ornitz, 2000; and references therein) . Fgfs signal through four receptor-tyrosine kinases (Fgfr1 to 24) through the MAP-Kinase pathway (Basilico and Moscatelli, 1992) . Among the known members of the Fgf family, Fgf3, Fgf8, Fgf17 and Fgf18 are expressed at the MHB in different species (Tannahill et al., 1992; Mahmood et al., 1996; Heikinheimo et al., 1994; Ohuchi et al., 1994; Crossley and Martin, 1995; Mahmood et al., 1995; Fu Èrthauer et al., 1997; Reifers et al., 1998; Hoshikawa et al., 1998; Xu et al., 1999; Ohbayashi et al., 1998 ). An essential function of Fgf8 in mediating the organizer activity of the MHB could be demonstrated through gain-and loss-of-function experiments (Crossley et al., 1996; Meyers et al., 1998; Reifers et al., 1998; Picker et al., 1999) . In addition, Fgf8 signaling has been implicated in the function of a second organizing cell population involved in forebrain patterning (Shimamura and Rubenstein, 1997; Houart et al., 1998; Shanmugalingam et al., 2000) , and in heart and otic placode induction and development Le Âger and Brand, in preparation) . In zebra®sh, only two members of the Fgf family, Fgf3 and Fgf8, have been described so far (Kiefer et al., 1996; Fu Èrthauer et al., 1997; Reifers et al., 1998) . Both fgfs are expressed at the MHB from gastrulation stages onwards (Fu Èrthauer et al., 1997; Reifers et al., 1998; Reifers and Brand, unpublished data) .
Here we report the isolation and characterization of a new member of the zebra®sh Fgf family, fgf17, which is expressed in a partially overlapping pattern compared to fgf8. The expression pattern of fgf17 at the MHB, the optic stalks and the somites, as well as gain-of-function experiments suggest important functions for Fgf17. The analysis of several zebra®sh MHB mutants and implantations of beads coated with Fgf8 protein reveal that Fgf17 probably serves an important function within the genetic hierarchy of the MHB organizer.
Results

Cloning and identi®cation of zebra®sh ®broblast growth factor 17
Using the mouse Fgf8 cDNA as a probe, we have isolated a new zebra®sh fgf from a genomic zebra®sh cosmid library.
Screening of a cDNA library with the cosmid clone as probe resulted in a 2.4 kb cDNA encoding a new fgf gene. The amino acid sequence of this gene is 70% identical to zebra®sh fgf8, 66% identical to mouse fgf8, 54% identical to mouse fgf17 and 50% identical to mouse fgf18 (Fig. 1A) . Phylogenetic sequence comparison indicates that the new fgf gene belongs to the fgf8/17/18 subgroup of fgfs (Fig.  1A,C) . A N-linked glycosylation site at position 140 is shared by all members of the fgf8/17/18 subgroup. A second N-linked glycosylation site at position 34 is characteristic for fgf8, but is lacking in mouse fgf17 and fgf18 and in the newly identi®ed zebra®sh fgf.
To determine whether the new gene is a duplicated fgf8, or a zebra®sh ortholog of other members of the fgf8/fgf17/ fgf18 subgroup, we have mapped its genetic position in the genome (Fig. 1D) . fgf8 maps to linkage group 13 to an area that is syntenic with mammalian chromosomes, in close proximity to pax2.1. The duplicated pax2.2 gene maps to linkage group 12 of the zebra®sh genome (J.H. Postlethwait, personal communication), and a duplicated fgf8 gene might therefore map close to pax2.2 on linkage group 12. However, the newly identi®ed fgf maps to linkage group 1 to an area which contains several genes with conserved synteny with mouse chromosome 14. Within the syntenic stretch, the new fgf occupies the position of murine fgf17. Together with the expression analysis (see below), these data show that the new fgf is the zebra®sh ortholog of mammalian fgf17, and will be referred to as zebra®sh fgf17.
Expression pattern of zebra®sh ®broblast growth factor 17
To study possible functions of fgf17, we examined expression in wild type embryos using whole-mount in situ hybridization (Fig. 2) . Unlike fgf8, fgf17 is not expressed during gastrulation (not shown). Expression becomes ®rst detectable at the 8-somite stage at the MHB in a region coincident with fgf8, and in the anterior somites (Fig. 2A±E) . Expression at the MHB is broad ventrally and is excluded from the dorsal-most part. From the 14-somite stage onwards, fgf17 is expressed in the optic stalks (Fig.  2F) . Expression in the somites becomes con®ned to the anteromedial margin of the maturing somite (Figs. 2G and 3E) . At 24 h, expression at the MHB is con®ned to the ventricular zone and excluded from the¯oorplate and the dorsal-most aspect of the neural tube (Fig. 2I ,J,P). Expression in the somites is lost after somitogenesis (Fig. 2M,N) . In addition, fgf17 is expressed in the otic vesicle at 24 h, in an area where the anterior macula will form (Fig. 2L) . At 30 h, expression starts in the hyoid, and at 36 h in the dorsal diencephalon close to the forming epiphysis (Fig. 2N,O) .
Comparative analysis of fgf17 and fgf8 expression patterns
Because fgf17 expression resembles the pattern of fgf8 expression (see Reifers et al., 1998) , we have directly compared the expression of these two genes by double in situ hybridization. The domains at the MHB are broadly overlapping, but only fgf8 is expressed in the dorso-anterior forebrain (Fig. 3A±D ). While fgf8 is expressed throughout the anterior margin of the maturing somites, fgf17 is expressed only in the anteromedial subpopulation (Fig.  3E,F) . Similarly, fgf17 expression can only be detected in a medial subpopulation of fgf8 expressing cells in the optic stalk, but not in facial ectoderm or nasal placode, and only weakly in the dorsal diencephalon (Fig. 3G±L ). In summary, the expression domains of fgf17 and fgf8 largely overlap, with fgf17 being expressed in a subpopulation of fgf8-positive cells, with the exception of the forebrain primordium where there is only fgf8 expression.
fgf17 can posteriorize and dorsalize zebra®sh embryos
To analyze potential functions of Fgf17 in the developing zebra®sh embryo, we performed gain-of-function experiments. Unlike fgf8 (Fu Èrthauer et al., 1997; Reifers et al., 1998) , injection of fgf17 RNA into wild type embryos at the one-to two-cell-stage results in a dose-dependent anterior shift at tailbud stage of pax2.1 and krox20 as markers for midbrain and rhombomeres 3 and 5, respectively (Fig. 4 , Table 1A ); control injections with lacZ RNA had no effect (not shown). Similar to fgf8, fgf17 misexpression causes severe expansion of both markers to ventral levels, which often encircle the embryo (Fig. 4) . This phenotype is indicative of dorsalization, as is more obvious during early somitogenesis, as monitored by in situ hybridization with myoD (Fig. 4 , Table 1B ). We conclude that like fgf8, fgf17 can exert a dorsalizing effect on the zebra®sh gastrula; in addition, fgf17 also causes posteriorization. Although these data show that fgf17 has a strong potency to in¯uence gastrula patterning, the observed effects cannot re¯ect an endogenous function of fgf17 in the zebra®sh embryo, since fgf17 is not expressed during gastrulation. More likely, fgf17 injection mimics the activity of other Fgf's (see Section 3). The early effects caused by fgf17 RNA injection so far precluded a gain-of-function analysis at later stages, e.g. in MHB development. Nevertheless, the difference in the response of the embryo towards fgf8 and fgf17 injection suggests that the encoded proteins have overlapping, but not identical properties.
fgf17 expression in zebra®sh MHB mutants
Although fgf17 orthologs have been isolated in several species, its position in the genetic hierarchy is unknown, partly because expression in mutant backgrounds has not yet been studied. We therefore studied fgf17 expression in several zebra®sh MHB and optic stalk mutants in a detailed time course (Fig. 5, Table 2 ). MHB expression of fgf17 in acerebellar (ace) mutant embryos, in which fgf8 is inactivated (Reifers et al., 1998) , is almost absent at its onset and is lost by the 16-somite stage (Fig. 5B,F) . aussicht (aus) is a dominant mutation causing an increase in fgf8 RNA expression (Heisenberg et al., 1999) ; and in mutant embryos fgf17 expression is initiated normally, but expands strongly at late somitogenesis (Fig. 5C,G) . spiel-ohne-grenzen (spg) mutant embryos do not form a proper MHB (Schier et al., 1996) and fail to initiate expression of fgf17 at the MHB, but recover the dorsal aspect of the expression domain at later stages (Fig. 5D,H) . Importantly, fgf17 is never expressed at the MHB in no isthmus (noi)/pax2.1-mutant embryos, which lack the MHB, cerebellum and midbrain at pharyngula stages (Fig. 5I±P) . Heterozygous noi 1/2 embryos show a clear reduction in expression when compared to their wild type siblings at the 14-to 20-somite stage; thus, expression of fgf17 depends on the copy number of the pax2.1 gene (Fig. 5) . These results show that fgf17 is clearly dependent on pax2.1 gene function, while fgf8 is required for most, but not all of the initial fgf17 expression, and for maintaining fgf17 expression at the MHB. The genes affected in aussicht and spiel-ohne-grenzen are similarly involved in maintaining fgf17 expression at the MHB. In the optic stalk, fgf17 expression is reduced in ace, spg and noi, but increased in aus mutants, suggesting a function of these genes in maintaining fgf17 expression in the optic stalk.
Inhibition of Fgf signaling causes loss of fgf17 expression
The altered expression of fgf17 in ace, spg and aus raised the possibility that fgf8 might act upstream of fgf17. We therefore analyzed the expression in wild type embryos where Fgf signaling has been blocked pharmacologically by treatment with SU5402. SU5402 blocks Fgfr1 activity by binding to a region of the kinase domain that is identical in all four Fgfrs, and is thought to be a potent inhibitor of all Fgfr function (Mohammadi et al., 1997; Johnson and Williams, 1993) . Treatment of wild type zebra®sh embryos with SU5402 results in a phenocopy of several aspects of the acerebellar mutant phenotype Shanmugalingam et al., 2000) . SU5402 treatment from tailbud stage onwards causes strong reduction of fgf17 expression at the MHB (Fig. 5Q,R) , similar to acerebellar mutants (Fig.  5A,B) . This ®nding further supports the notion that fgf17 expression depends on activity of Fgfs in general, and Fgf8 in particular. Moreover, it suggests that the early remnant expression of fgf17 that is observed at the MHB in acerebellar mutants and in SU5402-inhibited embryos is independent of Fgf signaling.
fgf17 expression can be induced by an Fgf8 bead
To further test if Fgf8 itself could be an inducer of fgf17, we tested whether FGF8 protein-coated beads can induce expression of fgf17 upon implantation. Ectopic fgf17 expression was seen in two of ®ve wild type embryos implanted with an Fgf8-bead at the 14-somite stage, in the telencephalon at the 20-somite stage (Fig. 6A,B) and at 33 h in the ventral midbrain (Fig. 6C) . To examine whether Fgf8 protein can induce fgf17 expression at the MHB, we implanted Fgf8 beads into the MHB territory of homozygous ace mutants at the 14-somite stage, which normally lack fgf17 expression. At the 20-somite stage, fgf17 induction is observed in two of four ace embryos receiving an FGF8 bead (Fig. 6B) ; in the two non-induced embryos the bead was not located at the MHB. Control implantations of FGF8-soaked beads into the MHB territory of ace embryos lead to morphological rescue at 33 hpf, and induction of sprouty4, a target gene for Fgf8 signaling ( Fig. 6D ; M. Brand, unpublished observations). In all rescued cases the ace embryos showed a unilateral morphological constriction at the MHB close to the bead (Fig. 6D, arrow) . Implantation of PBS beads had no effect. In summary, Fgf8 is not only necessary but also suf®cient to induce expression of fgf17 at the MHB during the time of normal expression, and the induction correlates with the morphological rescue of the MHB in ace embryos.
Discussion
Our analysis demonstrates a dosage-dependent requirement for fgf17 for noi/pax2.1 activity in the MHB organizer and the optic stalk, and a requirement for acerebellar/fgf8 in correct onset and maintenance of the expression of fgf17 during MHB organizer development. Our gain-of-function experiments support both redundant and distinct functions of Fgf17 in comparison to Fgf8. In addition, the chromosomal location of Fgf17 provides a striking example for longrange conservation of genome organization between zebra®sh and mammals.
Cloning and expression of zebra®sh fgf17
Within the Fgf family, the newly isolated zebra®sh fgf ®ts into the subfamily which includes fgf8 and mammalian Fgf17 and Fgf18. Both in terms of sequence and expression patterns, this subgroup is distinct from other Fgf subgroups, including for instance Fgf7 and Fgf10, or Fgf4 and Fgf6 ( Fig. 1B ; Nishimura et al., 1999; Xu et al., 1999) . Although analysis of the amino acid identity suggests a slightly closer relationship to zebra®sh Fgf8 than to mammalian Fgf17 (66 versus 54%), comparison of expression patterns and the conservation of chromosomal synteny show that the new zebra®sh fgf is the ortholog of mammalian Fgf17, and will thus be designated fgf17. This situation most likely re¯ects the common ancestry of these genes, with the ancestral gene of Fgf8 and Fgf17 being more Fgf8 like, whereas the mouse Fgf17 has diverged more.
The overlapping expression pattern of fgf17 and fgf8 suggests redundant functions of these two Fgfs. In agreement with a functional redundancy of Fgf17 and Fgf8, it has been demonstrated, using a tissue-culture proliferation assay, that both Fgfs can activate the same Fgf receptors (Fgfr 2c, 3c and 4; Ornitz et al., 1996; Greene et al., 1998; Xu et al., 1999 Xu et al., , 2000 . Despite the broadly similar expression patterns, clear differences can be observed. Several structures express fgf8 but completely lack expression of fgf17 (apical ectodermal ridge, facial and nasal ectoderm, Fig. 4 . Effect of fgf17 misexpression on zebra®sh gastrula. The MHB primordium is visualized with pax2.1, rhombomere 3 and 5 by krox20 and adaxial and somitic mesoderm by myoD; location of the lacZ co-injected cells with an antibody to beta-gal (brown). For quanti®cation of the phenotypes, see Table 1 . (A± D) Misexpression of fgf17 in wild type embryos by RNA injection results in posteriorization. (A) pax2.1 (black arrowhead) and krox20 (red arrowhead) expression in uninjected or control-lacZ injected embryos is restricted to the dorsal side (control; dorsal view). (B±D) Dose-dependent anterior shift of these markers in an fgf17 injected embryos; note that expression of the normally dorsal marker expression now encircles the embryo, in the lateral view in (B) (indicative of dorsalization at this stage; compare also to Reifers et al., 1998) Reifers et al., 1998) . In addition, fgf8 expression is detectable much earlier in many structures like the MHB, the dorsal diencephalon and the somites (Fig. 2) . Similarly, murine FGF8 expression dominates during early developmental stages of the midbrain and the cerebellum (Xu et al., 2000) . These differences in expression pattern suggest that Fgf17 and Fgf8 have acquired unique functions which seem to be conserved throughout vertebrate evolution (Xu et al., 1999 (Xu et al., , 2000 .
Possible functions of zebra®sh fgf17 in MHB development
The RNA misexpression experiments resulted in a severe dorsalization of the embryo and in an anterior shift of midbrain and hindbrain markers. The early effects caused by fgf17 RNA injection so far precluded a gain-of-function analysis at later stages, e.g. in MHB development. Interestingly, Fgf17 dorsalizes the zebra®sh gastrula more strongly than Fgf8, even at low RNA concentrations (Fu Èrthauer et al., 1997; Reifers et al., 1998) . In a mouse tissue culture proliferation assay, Fgf17 and Fgf8 can activate the same Fgf receptor pro®le (Ornitz et al., 1996; Greene et al., 1998; Xu et al., 1999 Xu et al., , 2000 . The different effects of Fgf8 and Fgf17 in gastrulation might therefore re¯ect a higher af®nity of Fgf17 to the Fgf receptors that mediate Fgf signaling during gastrulation. Alternatively, the receptor speci®city in vivo could differ from the tissue culture situation, or could differ between mouse and zebra®sh. Although the injection assay reveals a potential biological activity for Fgf17, this cannot be its endogenous function, since endogenous Fgf17 is not normally present in the gastrula. fgf17 injection probably mimics the activity of other Fgfs that are present, such as fgf8 and fgf3 (Fu Èrthauer et al., 1997; Reifers et al., 1998; Lun et al., unpublished observations) . The anterior shift of midbrain and hindbrain markers by fgf17 RNA injections is consistent with a role for Fgf signals in posteriorizing neural plate tissue (Lamb and Harland, 1995; Cox and Hemmati Brivanlou, 1995) . The posteriorizing effect of fgf17 is reminiscent of the in¯uence that Fgf3 exhibits on the neural plate, and fgf3 is expressed during gastrulation in zebra®sh embryos (Lun et al., unpublished observations) . However, in vitro Fgf3 activates a different subset of Fgf receptors (Ornitz et al., 1996) , suggesting that another Fgf might act as the endogenous posteriorizing signal.
The normal function of Fgf17 in zebra®sh MHB development is not clear. Since fgf17 is expressed during the maintenance phase of MHB development, it may ensure together with additional signals at the MHB the polarized expression of midbrain markers. Given the greater potency of fgf17 versus fgf8 in gastrulation, onset of fgf17 at this stage may re¯ect a new signaling capacity of the MHB organizer. In agreement with this possibility, expression of many marker genes is restricted to the posterior part of the midbrain primordium speci®cally during the maintenance phase of MHB development, around the time of fgf17 onset Reifers et al., 1998) . Our mapping of fgf17 may facilitate isolation of a mutant in fgf17, thus helping to further elucidate the role of Fgf17 in zebra®sh development by loss-of-function studies. À knock-out' of mouse Fgf17 con®rmed its importance in MHB development: mutants have a defective medial cerebellar anlage at late developmental stages, whereas early patterning events in the MHB region occur normally. Interestingly, this phenotype is increased in severity when the fgf17 mutants have only one copy of fgf8, suggesting that fgf8 and fgf17 may cooperate in regulating cerebellar size (Xu et al., 2000) .
fgf17 in the genetic hierarchy of the MHB organizer in zebra®sh
An important ®nding in our study is that in noi 2/2 embryos fgf17 expression is completely abolished at the MHB and the optic stalk, although the cells are present in the mutant at the time of onset of fgf17 expression in these tissues Pfeffer et al., 1998) . noi/ pax2.1 is therefore a crucial upstream component in the pathway that activates fgf17, consistent with the colocalization of the expression domains at this stage . Interestingly, the expression of fgf17 at the MHB and the optic stalk also depends on the gene dose of pax2.1 at midsomitogenesis stages, since in noi 1/2 embryos fgf17 expression is clearly reduced. Such haploinsuf®ciency has also been reported for the human PAX2 gene, where heterozygous patients show optic nerve coloboma and vesicouretral re¯ux syndrome (Sanyanusin et al., 1995) . Our observation suggests that noi heterozygous ®sh might provide useful models for these human diseases.
Our study supports a model of sequential or parallel action of fgf8 and fgf17 in MHB organizer development. Gain-and loss-of-function experiments argue in favor of an essential role of Fgf signaling in mediating the MHB organizer activity. FGF8-soaked beads can mimic the organizing activity of the isthmus and induce ectopic midbrain or cerebellar structures when implanted in the caudal forebrain of chick (Crossley et al., 1996; Martinez et al., 1999) or zebra®sh (Picker, Reifers and Brand, unpublished) embryos. On the other hand, inactivation of the Fgf8 gene in mice (Meyers et al., 1998) and zebra®sh (Reifers et al., 1998) results in loss of the MHB organizer. Finally, an essential role has been demonstrated for Fgf8 signaling for growth and polarity of the midbrain (Picker et al., 1999; Lee et al., 1997) . In zebra®sh, Fgf8 is required for the maintenance of the MHB organizer as shown by the analysis of the zebra®sh ace mutant (Reifers et al., 1998) . fgf17 expression starts around the onset of the maintenance phase, consistent with a possible function in the MHB organizer. The gradual disappearance of fgf17 expression at the MHB in ace mutant embryos is reminiscent of other MHB marker genes (Reifers et al., 1998) , suggesting that fgf17 is not only or not directly dependent on fgf8 gene function. In accordance, the inhibitor experiments demonstrate that at least the onset of fgf17 expression at the MHB is partially independent of Fgf signaling. Expression of pax2.1 and eng2 are strongly reduced and subsequently lost in the maintenance phase in ace mutant embryos. Given the absolute requirement for pax2.1, reduction of fgf17 may be the indirect consequence of the reduction of pax2.1 in ace mutants. Furthermore, the reexpression of fgf17 at the MHB in ace mutant embryos at 20-somite stage after implantation of an FGF8-soaked bead supports an indirect mechanism, since FGF8 beads can induce ectopic En and Pax2 expression in the developing neural plate (Crossley et al., 1996; Martinez et al., 1999; Shamim et al., 1999) . Similarly, upregulation of fgf17 expression at the MHB in aus mutant embryos is in agreement with this view, since fgf8 and pax2.1expression is upregulated at the MHB in aus, resulting in a broader expression of eng genes (Heisenberg et al., 1999) . Future studies will determine whether the induction of fgf17 expression is a direct effect of Pax2.1 activation or occurs indirectly through Eng activation.
Experimental procedures
Zebra®sh were raised and kept under standard laboratory conditions at about 278C (Wester®eld, 1994; Brand and Granato, 2000) . Mutant carriers were identi®ed by random intercrosses. To obtain embryos showing the mutant phenotype, two heterozygous carriers for a mutation were crossed to one another. Typically, the eggs were spawned synchronously at dawn of the next morning, and embryos were collected, sorted, observed and ®xed at different times of development at 28.58C. In addition, morphological features were used to determine the stage of the embryos, as described by Kimmel et al. (1995) . In some cases, 0.2 mM phenylthiourea (PTU) was added to prevent melanization. Isolation and characterization of acerebellar (ace ti282a ), no isthmus (noi tu29a ), spiel-ohne-grenzen (spg m216 ) and aussicht (aus t294 ) are described in Brand et al. (1996) ; Reifers et al. (1998); Brand et al. (1996) ; Lun and Brand (1998) ; Schier et al. (1996) ; Heisenberg et al. (1999) , respectively.
Isolation of fgf17 cDNA
A genomic zebra®sh cosmid library was screened with the mouse Fgf8 cDNA resulting in a 2 kb fragment which was used to screen a zebra®sh cDNA library (_ZAPII, 9-16 hpf). The obtained phage contained a cDNA of 2351 bp (Accession number xxx). Both clones were sequenced and analyzed using the Analyze (MacMolly w Tetra, Version 1.2.3, Soft Gene GmbH) and the ClustalX software. The cDNA contained an open reading frame of 636 bp encoding a protein of 212 amino acids with a calculated molecular weight of 24 978 kDa. The exon/intron structure was determined by comparing the genomic clone with the cDNA clone. Exon/intron junctions have been con®rmed by sequencing.
Mapping of fgf17 on the zebra®sh genome
We mapped zebra®sh fgf17 on the Goodfellow T51 radiation hybrid panel (Research Genetics) using the following primer pair: CGA CCC AGG AAA GCC ATG CAG ACC C (5 H primer) and TCA TTG TCC CAG AAC ATA CTG TTC C (3 H primer). The 5 H primer binds in the open reading frame, while the 3 H primer is located in the 3 H UTR of the gene. The PCR gives a fragment of 329 bp. PCR, gel electrophoresis and scoring was done as described in Geisler et al. (1999) . PCR reactions were run in duplicates and uncertain results were con®rmed in a third run.
Whole-mount in situ hybridization
In situ hybridizations were done as described by Reifers et al. (1998) . Probes and wild type expression patterns are described: fgf8 (Fu Èrthauer et al., 1997; Reifers et al., 1998) , krox20 (Oxtoby and Jowett, 1993) , myoD (Weinberg et al., 1996) and pax2.1 (Krauss et al., 1991) .
RNA injections
RNA injections were done as described by Reifers et al. (2000) . During injection, RNA was deposited into the cytoplasm of one-to two-cell-stage embryos. The embryos were ®xed at tailbud stage or at seven-to ten-somite stage prior to in situ hybridization and antibody staining.
Bead implantations and inhibitor treatment
Bead implantations and inhibitor treatment were done as described by Reifers et al. (2000) . FGF8b or PBS control beads were implanted in various brain regions of wild type and acerebellar mutant embryos at 13 somites, the embryos were ®xed at 20 somites or 33 hpf prior to ISH. For pharmacological inhibition of Fgfr activity, wild type embryos were treated with SU5402 (Calbiochem; Mohammadi et al., 1997) at 8 mm in embryo medium at 28.58C in the dark for the indicated time periods.
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